Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
TECHNICAL VIEW MOVING AVERAGE 21 DAYS
50 DAYS
100 DAYS
200 DAYS
NIFTY
8006
7824
7544
6946
BANK NIFTY
15716
15497
15052
13235
NIFTY PIVOT REPORT DAILY
R2 8283
R1 8179
PP 8128
S1 8076
S2 7972
WEEKLY
R2 8507
R1 8259
PP 8253
S1 8011
S2 7763
MONTHLY
R2 8659
R1 8297
PP 8116
S1 7935
S2 7574
BANK NIFTY PIVOT REPORT DAILY
R2 16699
R1 16426
PP 16290
S1 16154
S2 15881
WEEKLY
R2 17035
R1 16521
PP 16264
S1 16007
S2 15493
MONTHLY
R2 17815
R1 16716
PP 16167
S1 15618
S2 14519
NSE EQUITY DAILY LEVELS COMPANY
R3
R2
R1
PP
S1
S2
S3
ACC ALBK
EQ 1575 EQ 125
1552 122
1539 121
1528 119
1515 118
1505 117
1481 114
AMBUJACEM ASIAN PAINT AXISBANK BAJAJ-AUTO BANKBRODA BANKINDIA BHEL BHARTIARTL CIPLA
EQ EQ EQ EQ EQ EQ EQ EQ EQ
217 680 422 2388 932 295 227 414 604
216 674 419 2369 925 292 224 411 597
214 664 416 2345 919 289 222 408 586
213 658 413 2325 912 286 218 405 580
211 649 411 2301 906 283 216 402 569
208 633 405 2257 893 277 211 397 551
221 695 427 2432 954 301 233 420 622
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
COALINDIA DLF DRREDDY GAIL GRASIM HCLTECH HDFC HDFCBANK HEROMOTOCO HINDALCO HINDUNILVR ICICIBANK ITC INDUSIND BANK INFY JINDALSTEL KOTAKBANK LT M&M MRF MARUTI ONGC ORIENTBANK RANBAXY RCOM RELCAPITAL RELIANCE RELINFRA RPOWER SBIN SESAGOA SUNPHARMA TATAMOTORS TATAPOWER TATASTEEL UNIONBANK ACC
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
373 181 3051 481 3710 1673 1075 871 2845 182 778 1599 363 644 3790 247 1094 1649 1418 32945 3054 447 292 665 117 573 1041 728 78.90 2656 296 868 528 93.35 531 221 1575
365 178 3009 471 3666 1648 1061 862 2789 175 768 1582 358 636 3732 241 1079 1617 1397 32171 3003 438 286 636 113 560 1028 711 77.25 2628 291 837 522 91.70 524 215 1552
361 177 2984 466 3647 1633 1056 858 2768 171 763 1574 357 631 3699 238 1072 1597 1388 31793 2984 432 283 623 111 552 1020 700 76.15 2614 289 823 519 90.65 521 213 1539
358 175 2967 461 3623 1623 1047 853 2733 169 758 1565 354 629 3674 236 1064 1586 1377 31397 2952 429 280 606 110 547 1016 693 75.60 2601 287 805 516 90.05 517 210 1528
353 174 2942 456 3603 1608 1042 849 2712 165 753 1557 352 624 3641 233 1056 1565 1368 31019 2933 423 277 594 107 539 1008 682 74.50 2587 285 791 513 89.05 514 208 1515
350 172 2925 451 3580 1598 1033 844 2678 163 748 1548 349 621 3616 230 1047 1554 1357 30623 2901 420 274 577 106 534 1003 676 73.95 2573 283 773 510 88.40 511 205 1505
342 169 2883 441 3537 1572 1019 836 2622 156 738 1531 344 614 3558 225 1034 1523 1337 29849 2850 411 268 548 103 521 991 658 72.30 2546 278 742 504 86.75 504 199 1481
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
NSE WEEKLY NEWS UPDATE ✍ Sebi censures BSE for taking late bids in NMDC sell off Market regulator Sebi on Thursday censured BSE for accepting an order of 4.55 crore shares in the divestment of government-owned NMDC after the closing time due to a technical glitch in December 2012. The market regulator also asked BSE to engage external consultants to look into the matter in further detail and fix responsibilities. In the NMDC divestment, the government sold about 39.6 crore shares and the issue was subscribed nearly two times with the total demand at about 73.2 crore shares. Of the total book size, while the order for 4.55 crore shares came in at the fag end of the trading hours, the money from the custodian bank, Citibank NA, was transferred to the designated bank account for NMDC offer for sale about two and half hours after the close of trading on that day. Sebi censured BSE for accepting this bid that was confirmed after the close of trading.
✍ ICICI Bank board approves five-for-one stock split ICICI Bank, country's largest private lender, today approved sub-division of one equity share into five with the aim to increase liquidity of scrip. "The board of directors of ICICI BankBSE -0.06 % has considered and approved the subdivision (split) of one equity share of the bank having a face value of Rs 10 into five equity shares of face value of Rs 2 each," the bank said in a statement. Each American Depositary Share (ADS) of ICICI Bank will continue to represent two underlying equity shares as at present, it said. The number of ADSs held by an American Depositary Receipt holder would consequently increase in proportion to the increase in number of equity shares. Thus, the underlying equity shares would rise to 10 with the split.
✍ Jaiprakash Associates falls as Goldman Sachs downgrades stock Jaiprakash Associates fell about 4 per cent after Goldman Sachs downgraded Jaiprakash to 'neutral' from 'buy' and removed it from Asia Pacific buy list. The global investment bank cited uncertainty after one of its promoters sold 1.45 per cent stake.
✍ Disinvestment in Coal India, ONGC, NHPC to fetch record Rs 45,000 crore The government on Wednesday kicked off the most ambitious disinvestment programme, targeting to mop up a record Rs 45,000 crore by selling shares in blue chips public sector companies — Coal India, ONGC and National Hydroelectric Power Corporation (NHPC). While the exact dates are yet to be finalized, SAIL's disinvestment, which was cleared earlier, is
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
likely later this month, with a 10% stake sale in Coal India expected around Diwali. The energy behemoth will help the government raise around Rs 23,600 crore based on its current share price. If prices hold, this sale alone is going to match the best ever disinvestment receipts of Rs 23,957 crore in 2012-13, when the government had sold shares of NTPC and NMDC, among others. ONGC, where the government can garner close to Rs 19,000 crore via a 5% sale, is expected later in the year as the government is awaiting clarity on gas prices before the issue, sources in the government told TOI. Somewhere during the course of the year, it will also sell 11.3% in NHPC which, going by current price, will help generate around Rs 3,000 crore.
� Sun Pharma falls 4%, Taro recalls anti-clotting drug Shares of Sun Pharma slipped 4 percent intraday Friday on drug recall concern. Its subsidiary Taro Pharmaceutical has recalled an anti-clotting drug, Warfarin generic from the US markets due to USFDA concerns on quality. Taro has recalled two lots of a key drug on September 2, citing failed content uniformity specifications, according to drug regulator. The drug contributes nearly 5 percent of Taro's sales, analysts say. The stock has been under pressure from yesterday as the US drug regulator made a surprise audit at the pharma major's Halol facility in Gujarat. It is learnt that majority of ex-Taro products of Sun Pharma for the US market come from Halol facility, the largest plant of the company, which supplies 40 percent of US sales and contributes 25 percent to consolidated profit.
� Cigarette stocks fall amid reports of tough tobacco policy Shares of cigarette companies ITC, Godfrey Phillips India and VST Industries fell by as much as 6 per cent amid media reports that the government may tighten norms to put check on smoking. Stocks of Godfrey Phillips slumped 6.09 per cent to Rs 2,990, while ITCBSE 1.40 % was down by 1.85 per cent to Rs 351.05 and VST Industries lost 3.58 per cent to Rs 1,625.05 on the BSE. According to reports, the government is considering a proposal to ban sale of loose cigarettes. The health ministry has also proposed to raise age limit for consumption and increasing the fine for smoking in public spaces to Rs 20,000 from Rs 200, apart from making this a cognisable offence, it said.
� Snowman Logistics surges 68% on listing day Snowman Logistics has seen huge buying appetite on listing day itself, beginning the trade at Rs 75 (the equilibrium price arrived in pre-opening session) on the Bombay Stock Exchange. That is 60 percent returns for investors over the issue price of Rs 47, which is more than grey market premium of 25-30 percent premium. It means the person, who has applied for 300 shares (the minimum bid quantity) by paying Rs 14100, received a whopping profit of Rs 8400
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
on day one (Rs 28 per share premium over issue price). The stock was quoting at Rs 78.75 (the highest level in today's trade), up Rs 31.75, or 67.55 percent on the BSE. The current market capitalisation of the company stands at Rs 1,310 crore. Its public issue had received excellent response from investors, oversubscribing 59.75 times supported by retail subscription with 41.26 times, non-institutional investors with 221.79 times and qualified institutional buyers with 16.98 times.
✍ L&T bags orders worth Rs 1,920 crore in hydrocarbon business Larsen & Toubro (L&T) has bagged contracts worth Rs 1,920 crore in its hydrocarbon business in the offshore and onshore segments. The company secured an offshore contract worth Rs 1,340 crore from Oil and Natural Gas Corporation (ONGC). The scope of the contract includes engineering, procurement, construction and installation of five wellhead platforms at the Mumbai High North field of ONGC.
✍ Rajiv Rattan takes over Indiabulls Power with Rs 360 crore buyout Rajiv Rattan, one of the three promoters of the India Bulls group, on Sunday announced having taken control of the group's two power companies after buying out Saurabh Mittal's stake for Rs 360 crore in Indiabulls Infrastructure and Power. After buying out Mittal's five per cent holding in Indiabulls Infrastructure and Power, Rattan infused fresh equity into Indiabulls Power through his private company. Rattan will hold five percent directly in the company.
✍ BSNL, MTNL merger likely by July next year The much-awaited merger of telecom PSUs, BSNL and MTNL, is likely to take place by July next year as the two companies look at synergising operations by offering services as a single entity. At present, BSNL offers services in the whole country, except Delhi and Mumbai. MTNL provides telecom services in these two zones.
✍ FIIs pump in Rs 9,000 crore in first week of September Continuing their bet on the government's reforms agenda, overseas investors have poured in nearly Rs 9,000 crore in the Indian capital market in the first week of the month. Net investments by foreign investors in the equity market were Rs 3,972 crore ($656 million) from September 1-5, while they infused a net amount of Rs 5,013 crore ($828 million) in the Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
debt market during the period, taking the total to Rs 8,986 crore ($1.5 billion), as per the latest data.
✍ ICICI Bank raises $500 million selling bonds to overseas investors ICICI Bank Ltd, India’s largest private sector bank by assets, raised $500 million late on Thursday by selling bonds to investors in Europe and Asia, two bankers familiar with the matter said. The bonds, maturing in five-and-a-half years, were subscribed more than four times, one of the bankers cited above said. “Investors bid a total of more than $2 billion, indicating solid investor interest for the bonds,” the banker said.
✍ Mahindra and Mahindra falls nearly 2% on Kotak downgrade Mahindra and MahindraBSE 0.99 % Ltd shares fell 1.7 per cent after Kotak Institutional Equities cut the auto maker to 'reduce' from 'add' and lowered target price to Rs 1,310 from Rs 1,404. Kotak cited valuations as the key reason. Adding Mahindra and Mahindra has lost 13 per cent market share in the utility vehicle segment over the past two years.
✍ Wockhardt rallies over 3%, hits 52-week high on merger plans WockhardtBSE 1.66 % rallied as much as 3.3 per cent in trade on Wednesday to hit its fresh 52week high of 871.40, after the drug maker said that it plans to merge two wholly owned subsidiaries with itself as part of a new business realignment. The company said in a statement to the stock exchanges on Tuesday that it will consider and approve amalgamation of two wholly owned subsidiaries viz Wockhardt Biopharm and Vinton Healthcare with Wockhardt.
✍ Biocon rallies over 1% on buying stake in Syngene International Biocon Ltd rallied as much as 1.6 per cent in trade on Wednesday, after the drug maker acquired GE Capital's entire 7.69 per cent stake in its research services subsidiary Syngene International for Rs 215.38 crore. Biocon Research Ltd, a wholly owned subsidiary of Biocon, has entered into an agreement with GE Equity International Mauritius, a subsidiary of GE Capital Corporation to purchase the latter's investment in Biocon's research services subsidiary, Syngene International for an agreed consideration of Rs 215.38 crore.
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)
This Document has been prepared by Ways2Capital (A Division of High Brow Market Research Investment Advisory Pvt Ltd). The information, analysis and estimates contained herein are based on Ways2Capital Equity/Commodities Research assessment and have been obtained from sources believed to be reliable. This document is meant for the use of the intended recipient only. This document, at best, represents Ways2Capital Equity/Commodities Research opinion and is meant for general information only. Ways2Capital Equity/Commodities Research, its directors, officers or employees shall not in any way to be responsible for the contents stated herein. Ways2Capital Equity/Commodities Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This document is not to be considered as an offer to sell or a solicitation to buy any securities or commodities. All information, levels & recommendations provided above are given on the basis of technical & fundamental research done by the panel of expert of Ways2Capital but we do not accept any liability for errors of opinion. People surfing through the website have right to opt the product services of their own choices. Any investment in commodity market bears risk, company will not be liable for any loss done on these recommendations. These levels do not necessarily indicate future price moment. Company holds the right to alter the information without any further notice. Any browsing through website means acceptance of disclaimer.
Web: www.ways2capital.com | Mail: info@ways2capal.com | Contact: 1800-3010-2007 (Toll Free)